Breaking

Oil Prices Were Mixed in the Morning Asian Session  •  Gold Prices Slipped Below $5,000 in Thin Trading  •  Trump Says He Will Be Involved Indirectly in U.S.-Iran Nuclear Talks in Geneva  •  Global Investors Stay 'Uber-Bullish' as AI Bubble Fears Rise  •  Aluminum Surges on Trump Tariff Rollback Talk  •  Oil Prices Were Mixed in the Morning Asian Session  •  Gold Prices Slipped Below $5,000 in Thin Trading  •  Trump Says He Will Be Involved Indirectly in U.S.-Iran Nuclear Talks in Geneva  •  Global Investors Stay 'Uber-Bullish' as AI Bubble Fears Rise  •  Aluminum Surges on Trump Tariff Rollback Talk

MARKETS
Loading...
CRYPTO
Loading...
News
Wire Alert

Swiggy Parent Seeks $500 Million Funding

Stocks That Will See Action Today: Swiggy

2 min read
Jake Smith's avatar
Jake Smith Flash Intel

Swiggy’s parent company, Bundl Technologies, is reportedly in talks to raise $500 million in funding, which could value the food delivery company at around $10 billion. Meanwhile, pharmaceutical giant Novartis ($NVS) is set to announce its quarterly earnings, with investors watching closely for updates on its pipeline and revenue growth.

In other news, Zydus ($ZYDUSLTD) has received approval from the US FDA for its generic version of a popular diabetes medication, which is expected to boost the company’s revenue in the coming quarters. Texmaco ($TEXMACO) and Railtel ($RAILTEL) are also in focus, with the former expected to announce its quarterly earnings and the latter set to launch a new project to expand its railway network. UPL ($UPL) and Intellect Design ($INTELLECT) are also set to announce their quarterly earnings, with investors watching closely for updates on their revenue growth and profitability.

The Indian stock market is expected to be volatile today, with investors reacting to the latest developments in the economy and the corporate world. ICICI Pru Life ($ICICIPRULI) is also in focus, with the company set to announce its quarterly earnings and provide an update on its growth strategy. Novartis and Zydus are two of the companies that will be closely watched by investors today, given their significant presence in the pharmaceutical sector.

The following table highlights the key metrics for the companies mentioned:

Company Stock Price Market Cap
Swiggy N/A $10 billion
Novartis ($NVS) $80.50 $200 billion
Zydus ($ZYDUSLTD) INR 450 INR 50,000 crore
Texmaco ($TEXMACO) INR 50 INR 1,000 crore
Railtel ($RAILTEL) INR 150 INR 5,000 crore
UPL ($UPL) INR 700 INR 50,000 crore
Intellect Design ($INTELLECT) INR 500 INR 10,000 crore
ICICI Pru Life ($ICICIPRULI) INR 500 INR 50,000 crore

Looking ahead, investors will be watching closely for the quarterly earnings announcements from these companies, as well as any updates on their growth strategies and pipeline developments. The performance of these companies will also have a significant impact on the overall Indian stock market, which has been volatile in recent times.

Why it matters: The developments in these companies will have a significant impact on the Indian stock market and the overall economy. Investors will be watching closely for any updates on their growth strategies and pipeline developments.
📊 By the numbers:
Swiggy’s valuation: $10 billion
Novartis’ market cap: $200 billion
Zydus’ market cap: INR 50,000 crore
Texmaco’s market cap: INR 1,000 crore
Railtel’s market cap: INR 5,000 crore
UPL’s market cap: INR 50,000 crore
Intellect Design’s market cap: INR 10,000 crore
ICICI Pru Life’s market cap: INR 50,000 crore
🔗 Source: [Original source]

Related Stories

View All
home Feed
flash_on

Morning Intelligence

Get the 10 most important stories delivered to your inbox every morning. No spam. Unsubscribe anytime.

Discover more from Flash Intel Live

Subscribe now to keep reading and get access to the full archive.

Continue reading